• It’s Time to Embrace Whole Genome Sequencing

    It’s Time to Embrace Whole Genome Sequencing

    There are approximately 7000 rare diseases that are known, and according to the Rare Disease Day Organization, they affect anywhere from three to six percent of the world’s population. Moreover, approximately seventy percent of rare diseases are genetic. Whole-genome sequencing holds the promise of better understanding the links between an individual’s genome and rare disease. Dr. Madhuri Hegde, ... Read More
  • Laboratory Planning and Operations Recommendations in a Pandemic Environment

    Laboratory Planning and Operations Recommendations in a Pandemic Environment

    Laboratory planning and operating practices for safely reopening clinical and research laboratories (they differ) entail strict adherence to designs and protocols specific to each research type’s regulatory policies. Companies’ management teams will address the physical environment (distancing, fewer workstations, PPEs, and entries, exits, layouts) accordingly. At the same time, laboratory ... Read More
  • Lab Digitalization: Delivering Efficiency and Traceability

    Lab Digitalization: Delivering Efficiency and Traceability

    Despite the abundance of digital tools on the market, the life science laboratory trails behind in solutions for digital data capture and real-time consumables tracking, resulting in less productivity and resource waste. MilliporeSigma’s new LANEXO™ system is a vendor-neutral digital solution for inventory, safety and compliance management that provides complete lab coverage. Using radio-frequency... Read More
  • Novel Quantitative Sampling for Biofluids

    Novel Quantitative Sampling for Biofluids

    An Interview with Fasha Mahjoor, founder of Neoteryx LLC, on their novel quantitative sampling for biofluids. Read More
View Lab Intelligence
Page